Glioblastoma multiforme: Treatment with radiation and trhodothyronine

Wai Kwan Yung; William Steward; James E. Marks; Melvin L. Griem; John F. Mullan

doi:10.1016/0360-3016(76)90146-2

Glioblastoma multiforme: Treatment with radiation and trhodothyronine

Wai Kwan Yung, William Steward, James E. Marks, Melvin L. Griem, John F. Mullan

Neuro-Oncology

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

An analysis of patients with glioblastoma who were treated at the University of Chicago showed that (a) 32 patients who received surgery and irradiation (5000-6000 rad) had a median survival of 30 weeks; (b) 18 patients who received surgery, radiation (4200 rad), and triiodothyrosdne had a median survival of 60 weeks. A detailed analysis of the age, sex, clinical status of the patients, location, and pathology of the tumors showed no significant difference between the two groups. The marked increase in survival may indicate a radlosensitizing property of triiodothyronine.

Original language	English (US)
Pages (from-to)	645-650
Number of pages	6
Journal	International journal of radiation oncology, biology, physics
Volume	1
Issue number	7-8
DOIs	https://doi.org/10.1016/0360-3016(76)90146-2
State	Published - 1976

Keywords

Chemotherapy
Glioblastoma multiforme
Radiotherapy

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/0360-3016(76)90146-2

Cite this

@article{ef66b720c88f4470a3759ee6fa51e02d,

title = "Glioblastoma multiforme: Treatment with radiation and trhodothyronine",

abstract = "An analysis of patients with glioblastoma who were treated at the University of Chicago showed that (a) 32 patients who received surgery and irradiation (5000-6000 rad) had a median survival of 30 weeks; (b) 18 patients who received surgery, radiation (4200 rad), and triiodothyrosdne had a median survival of 60 weeks. A detailed analysis of the age, sex, clinical status of the patients, location, and pathology of the tumors showed no significant difference between the two groups. The marked increase in survival may indicate a radlosensitizing property of triiodothyronine.",

keywords = "Chemotherapy, Glioblastoma multiforme, Radiotherapy",

author = "Yung, {Wai Kwan} and William Steward and Marks, {James E.} and Griem, {Melvin L.} and Mullan, {John F.}",

year = "1976",

doi = "10.1016/0360-3016(76)90146-2",

language = "English (US)",

volume = "1",

pages = "645--650",

journal = "International journal of radiation oncology, biology, physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "7-8",

}

TY - JOUR

T1 - Glioblastoma multiforme

T2 - Treatment with radiation and trhodothyronine

AU - Yung, Wai Kwan

AU - Steward, William

AU - Marks, James E.

AU - Griem, Melvin L.

AU - Mullan, John F.

PY - 1976

Y1 - 1976

N2 - An analysis of patients with glioblastoma who were treated at the University of Chicago showed that (a) 32 patients who received surgery and irradiation (5000-6000 rad) had a median survival of 30 weeks; (b) 18 patients who received surgery, radiation (4200 rad), and triiodothyrosdne had a median survival of 60 weeks. A detailed analysis of the age, sex, clinical status of the patients, location, and pathology of the tumors showed no significant difference between the two groups. The marked increase in survival may indicate a radlosensitizing property of triiodothyronine.

AB - An analysis of patients with glioblastoma who were treated at the University of Chicago showed that (a) 32 patients who received surgery and irradiation (5000-6000 rad) had a median survival of 30 weeks; (b) 18 patients who received surgery, radiation (4200 rad), and triiodothyrosdne had a median survival of 60 weeks. A detailed analysis of the age, sex, clinical status of the patients, location, and pathology of the tumors showed no significant difference between the two groups. The marked increase in survival may indicate a radlosensitizing property of triiodothyronine.

KW - Chemotherapy

KW - Glioblastoma multiforme

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0017085869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017085869&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(76)90146-2

DO - 10.1016/0360-3016(76)90146-2

M3 - Article

C2 - 185171

AN - SCOPUS:0017085869

SN - 0360-3016

VL - 1

SP - 645

EP - 650

JO - International journal of radiation oncology, biology, physics

JF - International journal of radiation oncology, biology, physics

IS - 7-8

ER -

Glioblastoma multiforme: Treatment with radiation and trhodothyronine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this